Breast Cancer Chemoprevention among High-risk Women and those with Ductal Carcinoma In Situ-Reference-Cited by-同舟云学术

Breast Cancer Chemoprevention among High-risk Women and those with Ductal Carcinoma In Situ

Published:2015-04-16 Issue:4 Volume:21 Page:377-386
ISSN:1075-122X
Container-title:The Breast Journal
language:en
Short-container-title:Breast J

Author:

Reimers Laura L.¹,Sivasubramanian Parijatham S.²,Hershman Dawn¹²³,Terry Mary Beth¹³,Greenlee Heather¹³,Campbell Julie²,Kalinsky Kevin²³,Maurer Matthew²³,Jayasena Ramona³,Sandoval Rossy³,Alvarez Maria³,Crew Katherine D.¹²³

Affiliation:

1. Department of Epidemiology; Mailman School of Public Health; Columbia University; New York New York

2. Department of Medicine; College of Physicians & Surgeons; Columbia University; New York New York

3. Herbert Irving Comprehensive Cancer Center; Columbia University; New York New York

Funder

National Institutes of Health

Publisher

Hindawi Limited

Subject

Oncology,Surgery,Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/tbj.12418/fullpdf

Reference53 articles.

1. Integrating tools for breast cancer risk assessment, risk reduction, and early detection;Ward;Cancer Epidemiol Biomarkers Prev,2010

2. Estimates of the number of US women who could benefit from tamoxifen for breast cancer chemoprevention;Freedman;J Natl Cancer Inst,2003

3. Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study;Fisher;J Natl Cancer Inst,1998

4. Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study;Fisher;J Natl Cancer Inst,2005

5. Twenty-year follow-up of the Royal Marsden randomized, double-blinded tamoxifen breast cancer prevention trial;Powles;J Natl Cancer Inst,2007

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Spatial N-glycomics of the normal breast microenvironment reveals fucosylated and high-mannose N-glycan signatures related to BI-RADS density and ancestry;Glycobiology;2024-06-13

2. Breast Cancer Polygenic-Risk Score Influence on Risk-Reducing Endocrine Therapy Use: Genetic Risk Estimate (GENRE) Trial 1-Year and 2-Year Follow-Up;Cancer Prevention Research;2023-12-28

3. Comparing Breast Cancer and Cardiovascular Disease Risk and Use of Chemoprevention and Statins among Women with High-risk Breast Lesions;Cancer Prevention Research;2023-10-24

4. Perceptions of Breast Cancer Risks Among Women Receiving Mammograph Screening;JAMA Network Open;2023-01-23

5. Intraductal delivery of nanocarriers for ductal carcinoma in situ treatment: a strategy to enhance localized delivery;Nanomedicine;2022-10